CareLit Fachartikel

Terlipressin in 33 Patients with Hepatorenal Syndrome: Results of a Retrospective Study on Duration and Dose of Terlipressin Therapy

V von Kalckreuth, F Glowa, AW Lohse, U Denzer · Zeitschrift für Gastroenterologie · 2008 · Heft 01

Dokument
1168246
CareLit-ID
Jahr
2008
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
V von Kalckreuth, F Glowa, AW Lohse, U Denzer
Ausgabe
Heft 01 / 2008
Seiten
–
Erschienen: 2008-01-23 00:00:00
ISSN
0044-2771
DOI
10.1055/s-2008-1037659

Zusammenfassung

Introduction: Terlipressin is known to improve renal function in patients with liver cirrhosis and hepatorenal syndrome (HRS). This study investigated retrospectively effects of duration and dose of terlipressin therapy and predictive factors for positive response to treatment. Methods: HRS was defined as increase in serum creatine value >1.5mg/dL and decrease of glomerular filtration rate to

Schlagworte

Hepatorenal Syndrome Liver Cirrhosis Retrospective Analysis Terlipressin Creatinine After Creatine Zeitschrift für Gastroenterologie